Image

A Collaborative Pain Management Intervention for Improving Cancer Pain Management in Rural and Hispanic Cancer Survivors

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in rural and Hispanic cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. Hispanic and rural-dwelling cancer survivors stand to benefit the most from electronic health record innovations, as each of these health disparities populations experience profound disparities in pain outcomes, including marked under- and over-prescribing of opioids. Digitally facilitated solutions are especially well matched for these patients, and can be customized to address their needs. The ASCENT intervention provides patients with an educational guide that describes techniques for addressing cancer pain, and uses community health workers and pain care managers to coach patients through a personalized pain management plan. This study may help researchers learn how pain management strategies can improve cancer pain and lower risk of opioid exposure and dependency in rural and Hispanic cancer survivors.

Description

PRIMARY OBJECTIVE:

I. To test a validated collaborative care model-based intervention aimed at improving pain control among rural dwelling and Hispanic cancer survivors by promoting multimodal pain care (MMPC) to reduce inappropriate opioid use and by addressing social determinants of health (SDOH) that impede a patient's access to appropriate care.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive enhanced usual care, which includes access to the educational and pain self-management materials developed for the ASCENT trial (the ASCENT guide).

ARM II: Patients receive the ASCENT guide and attend 3 video or phone calls over 30 minutes each with their community health worker (CHW) and/or pain care manager (PCM). During the first call, patients discuss barriers to receiving help for their pain with their CHW. During the second call, patients work with their PCM to develop an action plan for addressing their pain using the different techniques and interventions detailed in the ASCENT guide. During the third and final call, patients meet with both their CHW and PCM to discuss specialist recommendations for their pain management plan. After the final visit, patients will be contacted by the CHW or PCM every other week to monitor their progress and may also be contacted as-needed based on the their reported pain intensity, symptoms, or reported barriers.

Eligibility

Inclusion Criteria:

  • A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site in the past 15 years
    • Including malignant hematology
      • Lymphoma
      • Myeloma
      • Chronic leukemias
  • Age >= 18
  • Numeric Rating Scale (NRS) pain score of >= 5/10
  • Pain that developed or worsened following cancer diagnosis
  • Fit the description of either rural or Hispanic or both

Exclusion Criteria:

  • Patient Health Questionnaire - 8 (PHQ8) score of >= 13
  • Hospice enrollment
  • Skilled nursing facility, inpatient rehabilitation facility, or long-term care placement
  • Encounters with Palliative Care or the Pain Clinic in the past two months or upcoming two months
  • Any mention of hospice referral in medical oncology encounter notes (assess through textual search of the Mayo Data Explorer)
  • Affirmative response to, "Are you usually confined to a bed or chair more than a third of your waking hours because of your health?"
  • Primary brain tumors
  • Acute leukemias
  • Currently homeless
  • Do not feel safe in their home
  • New or worsening chest pain, chest tightness, or chest pressure
  • Back pain that is associated with a new or worsening weakness, control of bowels/bladder, or difficulty walking
  • Lightheadedness, inability to keep down food or fluids, or vomiting blood or dark coffee-grounds-like material
  • New or worsening headaches that are associated with vision changes, nausea, balance issues, or problems with speech

Study details

Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

NCT06198010

Mayo Clinic

27 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.